Objective Assessment of Macular Function at Retinal and Cortical Levels

NCT ID: NCT03517241

Last Updated: 2018-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-15

Study Completion Date

2020-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research questions/hypotheses: About 15% of the population over 40 years of age are affected by diseases of the retina. Accurate measurement of the extent of visual field impairment is of highest importance for disease subtype diagnosis and severity classification. The current gold-standard approach for the assessment of macular sensitivity is microperimetry (MP) where the patient is asked to report whether or not visual stimuli presented at different positions within the visual field are detected. While this technique is a very straightforward approach and simple in its application, it is important to note that MP is psychophysical in nature and requires constantly high attentional performance of the patient throughout the examination period. As many patients suffering from retinal diseases are well over 65 years of age, they are unable to maintain such high levels of attention over longer periods and, thus, MP results may be biased. Retinotopic assessment using population receptive field (pRF) mapping based on functional magnetic resonance imaging (fMRI) offers an alternative by allowing for objective visual field testing, independent of patient performance. We have shown previously in healthy subjects that pRF allows for accurate detection of simulated central scotomata down to 2.35 degrees radius. Also, pilot data in patients with retinal scotomata showed strong correspondence between pRF and MP results, i.e. macular regions with reduced macular sensitivity and atrophy of outer retinal layers correlated well with pRF coverage maps showing reduced density of activated voxels. The aim of this project is to determine whether pRF mapping could serve as an alternative visual field testing method by: (1) assessing test-retest reproducibility of pRF and MP in clinical populations with stable retinal diseases (Stargardt disease, geographic atrophy) over a four-week period; (2) assessing visual field changes over a one-year period in patients suffering from acute retinal scotomata (branch retinal artery occlusions, full-thickness macular holes). All pRF mapping will be accompanied by MP measurements to allow for a direct comparison of the two techniques.

Scientific/scholarly innovation/originality of the project: The present project applies a novel approach for linking retinal function assessed with MP and pRF mapping in a representative patient population with acute and chronic retinal diseases. The project seeks to contribute to best practice methods for using fMRI to assess macular dysfunction both for documentation of the natural course of the disease and during therapy in a study setting.

Methods: fMRI uses pRF mapping to provide retinotopic data (pRF coverage maps) that are then correlated with the results of conventional ophthalmic testing including MP, visual acuity and contrast sensitivity testing, reading performance, optical coherence tomography and autofluorescence imaging.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Macula; Degeneration, Congenital or Hereditary Retina Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Geographic atrophy secondary to AMD

20 patients clinically diagnosed with geographic atrophy (GA) secondary to AMD.

functional magnetic resonance imaging (fMRI)

Intervention Type DIAGNOSTIC_TEST

Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex

Microperimetry (MP)

Intervention Type DIAGNOSTIC_TEST

MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.

Blue light fundus autofluorescence imaging (FAF)

Intervention Type DIAGNOSTIC_TEST

Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.

Visual testing

Intervention Type DIAGNOSTIC_TEST

Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Reading acuity and reading speed will be examined using Radner Reading Charts. Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm). Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.

Stargards disease

20 patients clinically and genetically diagnosed with Stargards disease (STGD)

functional magnetic resonance imaging (fMRI)

Intervention Type DIAGNOSTIC_TEST

Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex

Microperimetry (MP)

Intervention Type DIAGNOSTIC_TEST

MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.

Blue light fundus autofluorescence imaging (FAF)

Intervention Type DIAGNOSTIC_TEST

Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.

Visual testing

Intervention Type DIAGNOSTIC_TEST

Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Reading acuity and reading speed will be examined using Radner Reading Charts. Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm). Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.

Branch retinal artery occlusion

20 patients clinically diagnosed with branch retinal artery occlusion (BRAO)

functional magnetic resonance imaging (fMRI)

Intervention Type DIAGNOSTIC_TEST

Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex

Microperimetry (MP)

Intervention Type DIAGNOSTIC_TEST

MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.

Blue light fundus autofluorescence imaging (FAF)

Intervention Type DIAGNOSTIC_TEST

Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.

Visual testing

Intervention Type DIAGNOSTIC_TEST

Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Reading acuity and reading speed will be examined using Radner Reading Charts. Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm). Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.

Full thickness macular hole

20 patients clinically diagnosed with acute full thickness macular hole (FTMH) before and after macular surgery

functional magnetic resonance imaging (fMRI)

Intervention Type DIAGNOSTIC_TEST

Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex

Microperimetry (MP)

Intervention Type DIAGNOSTIC_TEST

MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.

Blue light fundus autofluorescence imaging (FAF)

Intervention Type DIAGNOSTIC_TEST

Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.

Visual testing

Intervention Type DIAGNOSTIC_TEST

Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Reading acuity and reading speed will be examined using Radner Reading Charts. Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm). Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.

Healthy controls

20 healthy control subjects. Visual acuity of 20/16- 20/32

functional magnetic resonance imaging (fMRI)

Intervention Type DIAGNOSTIC_TEST

Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex

Microperimetry (MP)

Intervention Type DIAGNOSTIC_TEST

MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.

Blue light fundus autofluorescence imaging (FAF)

Intervention Type DIAGNOSTIC_TEST

Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.

Visual testing

Intervention Type DIAGNOSTIC_TEST

Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Reading acuity and reading speed will be examined using Radner Reading Charts. Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm). Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

functional magnetic resonance imaging (fMRI)

Retinotopic mapping using functional magnetic resonance imaging (fMRI) is based on MR images acquired with blood-oxygenation-level-dependent (BOLD) contrast to reveal areas of neuronal activity in the visual cortex

Intervention Type DIAGNOSTIC_TEST

Microperimetry (MP)

MP allows localized testing of retinal sensitivity of foveal, parafoveal and even more peripheral macular regions

Intervention Type DIAGNOSTIC_TEST

Optical coherence tomography (OCT)

Optical Coherence Tomography (OCT) is a non-invasive diagnostic technique that renders an in vivo cross sectional view of the retina.

Intervention Type DIAGNOSTIC_TEST

Blue light fundus autofluorescence imaging (FAF)

Fundus autofluorescence imaging (FAF), is a non-invasive diagnostic technique focusing on the fluorescent properties of pigments in the retina to generate images.

Intervention Type DIAGNOSTIC_TEST

Visual testing

Best-corrected visual acuity will be measured using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Reading acuity and reading speed will be examined using Radner Reading Charts. Reading acuity is measured in logRAD unit (= reading equivalent of logMAR) and in critical font size (critical reading size), reading speed is measured in words per minute (wpm). Contrast sensitivity will be determined using Pelli-Robson contrast sensitivity charts.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 20 patients clinically diagnosed with GA secondary to AMD.
* 20 patients clinically and genetically diagnosed with STGD.
* 20 patients clinically diagnosed with BRAO.
* 20 patients clinically diagnosed with acute FTMH before and after macular surgery.
* 20 healthy control subjects. Visual acuity of 20/16- 20/32

Exclusion Criteria

* Presence of any other ophthalmological or neurological disease affecting visual function
* Cataract \> grade 2 (according to lens opacities system)
* Pregnancy
* Dyslexia
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Markus Ritter, MD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Markus Ritter, MD

Role: CONTACT

+4314040079400

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK1816/2014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Functional Assessments in Vision Impairment
NCT06908161 NOT_YET_RECRUITING
OCT in Retinal Vein Occlusions
NCT01992575 COMPLETED